Cytokines in clinical cancer immunotherapy

Pedro Berraondo; Miguel F. Sanmamed; María C. Ochoa; Iñaki Etxeberría; M. Ángela Aznar; José Luis Perez‐Gracia; María E. Rodriguez-Ruiz; Mariano Ponz‐Sarvisé; Eduardo Castañón; Ignacio Melero

doi:10.1038/s41416-018-0328-y

Keywords

ImmunotherapyCytokineImmune systemImmunologyCancer immunotherapyMedicineChimeric antigen receptorCytokine release syndromeClinical trialAntibodyCancerCancer researchBiologyInternal medicine

Affiliated Institutions

Related Publications

Chimeric Antigen Receptor Therapy

Carl H. June , Michel Sadelain

Interview with Dr. Carl June on chimeric antigen receptor therapy. (09:04)Download This review addresses T-cell engineering and synthetic immunity, with a focus on producing dur...

2018 New England Journal of Medicine 2080 citations

Cytokine release syndrome

Alexander Shimabukuro‐Vornhagen , Philipp Gödel , Marion Subklewe +6 more

During the last decade the field of cancer immunotherapy has witnessed impressive progress. Highly effective immunotherapies such as immune checkpoint inhibition, and T-cell eng...

2018 Journal for ImmunoTherapy of Cancer 1567 citations

Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia

Stephan A. Grupp , Michael Kalos , David M. Barrett +10 more

Chimeric antigen receptor-modified T cells with specificity for CD19 have shown promise in the treatment of chronic lymphocytic leukemia (CLL). It remains to be established whet...

2013 New England Journal of Medicine 3403 citations

Cancer immunotherapy using checkpoint blockade

Antoni Ribas , Jedd D. Wolchok

The release of negative regulators of immune activation (immune checkpoints) that limit antitumor responses has resulted in unprecedented rates of long-lasting tumor responses i...

2018 Science 6236 citations

Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients

F. Stephen Hodi , Marcus O. Butler , Darryl A. Oble +17 more

Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) functions as a negative regulator of endogenous and vaccine-induced antitumor immunity. The administration of fully human an...

2008 Proceedings of the National Academy o... 649 citations

Publication Info

Year: 2018
Type: review
Volume: 120
Issue: 1
Pages: 6-15
Citations: 1165
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Cytokines in clinical cancer immunotherapy

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

1165

OpenAlex

Cite This

APA Style

                            
                                
                                    Pedro Berraondo, 
                                
                                    Miguel F. Sanmamed, 
                                
                                    María C. Ochoa
                                
                                et al.
                            
                            (2018). 
                            Cytokines in clinical cancer immunotherapy. 
                            British Journal of Cancer
                            , 120
                            (1)
                            , 6-15.
                            https://doi.org/10.1038/s41416-018-0328-y
                        

Identifiers

DOI: 10.1038/s41416-018-0328-y